Back to search

Article

Safety Analysis of Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Real-World Study Based on the FAERS Database

2025-08-27

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Biologic therapies targeting type 2 inflammation have emerged as promising treatment options for Chronic Obstructive Pulmonary Disease (COPD), particularly in patients with eosinophilic phenotypes. However, their safety profiles in real-world clinical practice remain inadequately characterized. To address this gap, we conducted a pharmacovigilance study using...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3ced0fcc-7d44-5c37-877f-cebb87612c88
DOI
10.21203/rs.3.rs-7231453/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety Analysis of Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Real-World Study Based on the FAERS DatabaseDOI 10.21203/rs.3.rs-7231453/v1
Correlation of inhaled long-acting bronchodilators with cardiovascular adverse events in COPD patients: A real-world analysis of post-marketing surveillance dataSemantic proximity
Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease: A Narrative ReviewSemantic proximity
Immune-related adverse-event signals of durvalumab: cross-database pharmacovigilance analysis of WHO-VigiAccess and FAERS with comparative assessment versus atezolizumabSemantic proximity
Higher Rates of COVID-19 but Less Severe Infections Reported for Patients on Il-4/Il-13 Blocker: A Big Data Analysis of the WHO VigibaseSemantic proximity
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity
Adverse reactions associated with the use of ustekinumab in Crohn's disease treatment：an analysis based on the FAERS databaseSemantic proximity
Treatment of Chronic Spontaneous Urticaria With Benralizumab: Report of Primary Endpoint Completer Analysis, Secondary and Exploratory EndpointsSemantic proximity
Gastrointestinal adverse events associated with Riociguat: A pharmacovigilance study based on FDA adverse event reporting systemSemantic proximity
Clinical characteristics and drug utilisation patterns in patients with chronic cough: a retrospective cohort study using a Japanese claims databaseSemantic proximity
Biological Therapy for Chronic Obstructive Pulmonary Disease (COPD): Efficacy and SafetySemantic proximity
Age-Specific Differences in Omalizumab-Related Adverse Drug Reaction Signals between Children and Adults: An Analysis Based on the FAERS DatabaseSemantic proximity
Analysis of the adverse effects of used clinical Antisense Oligonucleotide drugs in DMD patients based on the FAERS databaseSemantic proximity
Select a neighboring publication to make it the new centre.